Skip to main content
SpringerLink
Log in

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Depressed people show effort-related motivational symptoms, such as anergia, retardation, lassitude, and fatigue. Animal tests can model these motivational symptoms, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT-2) inhibitor tetrabenazine. Tetrabenazine produces depressive symptoms in humans and, at low doses, preferentially depletes dopamine.

Objectives

The current studies investigated the effects of tetrabenazine on effort-based decision making using the T-maze barrier task.

Methods

Rats were tested in a T-maze in which the choice arms of the maze contain different reinforcement densities, and under some conditions, a vertical barrier was placed in the high-density arm to provide an effort-related challenge. The first experiment assessed the effects of tetrabenazine under different maze conditions: a barrier in the arm with 4 food pellets and 2 pellets in the no barrier arm (4–2 barrier), 4 pellets in one arm and 2 pellets in the other with no barrier in either arm (no barrier), and 4 pellets in the barrier arm with no pellets in the other (4–0 barrier).

Results

Tetrabenazine (0.25–0.75 mg/kg IP) decreased selection of the high cost/high reward arm when the barrier was present, but had no effect on choice under the no barrier and 4–0 barrier conditions. The effects of tetrabenazine on barrier climbing in the 4–2 condition were reversed by the adenosine A2A antagonist MSX-3 and the catecholamine uptake inhibitor and antidepressant bupropion.

Conclusions

These studies have implications for the development of animal models of the motivational symptoms of depression and other disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Argyropoulos SV, Nutt DJ (2013) Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? J Psychopharmacol 27(10):869–877

    Article  CAS  PubMed  Google Scholar 

  • Bardgett ME, Depenbrock M, Downs N, Points M, Green L (2009) Dopamine modulates effort-based decision making in rats. Behav Neurosci 123(2):242–251

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bella R, Pennisi G, Cantone M, Palermo F, Pennisi M, Lanza G, Zappia M, Paolucci S (2010) Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease. Gerontology 56(3):298–302

    Article  CAS  PubMed  Google Scholar 

  • Bourin M, Chenu F, Ripoll N, David DJ (2005) A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res 164(2):266–269

    Article  CAS  PubMed  Google Scholar 

  • Cagniard B, Balsam PD, Brunner D, Zhuang X (2006) Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology 31:1362–1370

    Article  CAS  PubMed  Google Scholar 

  • Caligiuri MP, Ellwanger J (2000) Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57:83–93

    Article  CAS  PubMed  Google Scholar 

  • Caligiuri MP, Gentili V, Eberson S, Kelsoe J, Rapaport M, Gillin JC (2003) A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. J Affect Disord 77:135–141

    Article  PubMed  Google Scholar 

  • Chen JJ, Ondo WG, Dashtipour K, Swope DM (2012) Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 34(7):1487–1504

    Article  PubMed  Google Scholar 

  • Cooper JA, Tucker VL, Papakostas GI (2014) Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. J Psychopharmacol 28:118–124

    Article  CAS  PubMed  Google Scholar 

  • Cousins MS, Sokolowski JD, Salamone JD (1993) Different effects of nucleus accumbens and ventrolateral striatal (DA) depletions on instrumental response selection in the rat. Pharmacol Biochem Behav 46:943–951

    Article  CAS  PubMed  Google Scholar 

  • Cousins MS, Atherton A, Turner L, Salamone JD (1996) Nucleus accumbens (DA) depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res 74:189–197

    Article  CAS  PubMed  Google Scholar 

  • Croxson PL, Walton ME, O’Reilly JX, Behrens TE, Rushworth MF (2009) Effort-based cost–benefit valuation and the human brain. J Neurosci 29(14):4531–4541

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I (2004) Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci U S A 101(21):8186–8191

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11(126)

  • Demyttenaere K, De Fruyt J, Stahl SM (2005) The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol 8:93–105

    Article  PubMed  Google Scholar 

  • Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MF, Bannerman DM (2005) Differential involvement of serotonin and dopamine systems in cost–benefit decisions about delay or effort. Psychopharmacology 179:587–596

    Article  CAS  PubMed  Google Scholar 

  • Fabre LF, Brodie HK, Garver D, Zung WW (1983) A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients. J Clin Psychiatry 44:88–94

    CAS  PubMed  Google Scholar 

  • Farrar AM, Pereira M, Velasco F, Hockemeyer J, Muller CE, Salamone JD (2007) Adenosine A(2A) receptor antagonism reverses the effects of (DA) receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology 191:579–586

    Article  CAS  PubMed  Google Scholar 

  • Farrar AM, Font L, Pereira M, Mingote SM, Bunce JG, Chrobak JJ, Salamone JD (2008) Forebrain circuitry involved in effort-related choice: injections of the GABAA agonist muscimol into ventral pallidum alters response allocation in food-seeking behavior. Neuroscience 152:321–330

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD (2010) Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and (DA) D2 receptors. Neuroscience 166:1056–1067

    Article  CAS  PubMed  Google Scholar 

  • Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P, Dube S, Thase ME (2013) Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety. doi:10.1002/da.22199

    PubMed Central  Google Scholar 

  • Ferré S, Quiroz C, Woods AS, Cunha R, Popoli P, Ciruela F, Lluis C, Franco R, Azdad K, Schiffmann SN (2008) An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 14(15):1468–1474

    Article  PubMed Central  PubMed  Google Scholar 

  • Floresco SB, Ghods-Sharifi S (2007) Amygdala-prefrontal cortical circuitry regulates effort-based decision making. Cereb Cortex 17(2):251–260

    Article  PubMed  Google Scholar 

  • Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33(8):1966–1979

    Article  CAS  PubMed  Google Scholar 

  • Font L, Mingote S, Farrar AM, Pereira M, Worden L, Stopper C, Port RG, Salamone JD (2008) Intra-accumbens injections of the adenosine A2A agonist CGS 21680 affect effort-related choice behavior in rats. Psychopharmacology (Berl) 199:515–526

    Article  CAS  Google Scholar 

  • Frank S (2009) Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators. BMC Neurol 9:62

    Article  PubMed Central  PubMed  Google Scholar 

  • Frank S (2010) Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington’s disease. Neuropsychiatr Dis Treat 5(6):657–665

    Article  Google Scholar 

  • Ghods-Sharifi S, Floresco SB (2010) Differential effects on effort discounting induced by inactivations of the nucleus accumbens core or shell. Behav Neurosci 124(2):179–191

    Article  PubMed  Google Scholar 

  • Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013) Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74(2):130–136

    Article  PubMed Central  PubMed  Google Scholar 

  • Guay DR (2010) Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinectic movement disorders. Am J Geriatr Pharmacother 8(4):331–373

    Article  CAS  PubMed  Google Scholar 

  • Gullion CM, Rush AJ (1998) Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry 44(10):959–972

    Article  CAS  PubMed  Google Scholar 

  • Hanff TC, Furst SJ, Minor TR (2010) Biochemical and anatomical substrates of depression and sickness behavior. Isr J Psychiatry Relat Sci 47(1):64–71

    PubMed  Google Scholar 

  • Hauber W, Sommer S (2009) Prefrontostriatal circuitry regulates effort-related decision making. Cereb Cortex 19(10):2240–2247

    Article  PubMed  Google Scholar 

  • Hockemeyer J, Burbiel JC, Muller CE (2004) Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson’s disease. J Org Chem 69:3308–3318

    Article  CAS  PubMed  Google Scholar 

  • Hodgson RA, Bertorelli R, Varty GB, Lachowicz JE, Forlani A, Fredduzzi S (2009) Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4–2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression. J Pharmacol Exp Ther 330(1):294–303

    Article  CAS  PubMed  Google Scholar 

  • Hudson AL, Lalies MD, Silverstone P (2012) Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Can J Physiol Pharmacol 90(6):803–809

    Article  CAS  PubMed  Google Scholar 

  • Kent TA, Preskorn SH, Glotzbach RK, Irwin GH (1986) Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation. Biol Psychiatry 21:483–491

    Article  CAS  PubMed  Google Scholar 

  • Keppel O (1991) Design and analysis: a researcher’s handbook, 3rd edn. Prentice-Hall, Englewood Cliffs

    Google Scholar 

  • Kitamura Y, Yagi T, Kitagawa K, Shinomiya K, Kawasaki H, Asanuma M, Gomita Y (2010) Effects of bupropion of the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. Naunyn Schmiedebergs Arch Pharmacol 382(2):151–158

    Article  CAS  PubMed  Google Scholar 

  • Koch M, Schmid A, Schnitzler HU (2000) Role of nucleus accumbens (DA) D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology 152:67–73

    Article  CAS  PubMed  Google Scholar 

  • Kurniawan IT, Seymour B, Talmi D, Yoshida W, Chater N, Dolan RJ (2010) Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J Neurophysiol 104(1):313–321

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Learned-Coughlin SM, Bergström M, Savitcheva I, Ascher J, Schmith VD, Långstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54:800–805

    Article  CAS  PubMed  Google Scholar 

  • Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly ÉJ, Koenen K, Ascherio A (2011) Coffee, caffeine, and risk of depression among women. Arch Intern Med 171(17):1571–1578

    Article  PubMed Central  PubMed  Google Scholar 

  • Mai B, Sommer S, Hauber W (2012) Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 12:74–84

    Article  PubMed  Google Scholar 

  • Markou A, Salamone JD, Bussey TJ, Mar AC, Brunner D, Gilmour G, Balsam P (2013) Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev 37(9 Pt B):2149–2165

    Article  PubMed  Google Scholar 

  • McGinty VB, Lardeux S, Taha SA, Kim JJ, Nicola SM (2013) Invigoration of reward seeking by cue and proximity encoding in the nucleus accumbens. Neuron 78:910–922

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Milea D, Guelfucci F, Bent-Ennakhil N, Toumi M, Auray JP (2010) Antidepressant monotherapy: a claims database analysis of treatment changes and treatment duration. 32(12):2057–2072

  • Mingote S, Font L, Farrar AM, Vontell R, Worden LT, Stopper CM, Port RG, Sink KS, Bunce JG, Chrobak JJ, Salamone JD (2008) Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J Neurosci 28:9037–9046

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Muller CE, Salamone JD (2009) The adenosine A2A antagonist MSX-3 reverses the effects of the (DA) antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology 204:103–112

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nicola SM (2010) The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior. J Neurosci 30(49):16585–16600

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nowend KL, Arizzi M, Carlson BB, Salamone JD (2001) D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 69:373–382

    Article  CAS  PubMed  Google Scholar 

  • Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD (2010) Differential effects of selective adenosine antagonists on the effort-related impairments induced by (DA) D1 and D2 antagonism. Neuroscience 170:268–280

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD (2013a) Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev 37:2015–2025

    Article  CAS  PubMed  Google Scholar 

  • Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD (2013b) Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33(49):19120–19130

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nunes EJ, Randall PA, Estrada A, Epling B, Hart E, Lee CE, Baqi Y, Müller CE, Correa M, Salamone JD (2014) Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task. Psychopharmacology 231:727–736

    Article  CAS  PubMed  Google Scholar 

  • Pae CU, Lim HK, Han C, Patkar AA, Steffens DC, Masand PS, Lee C (2007) Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Rev Neurother 7(10):1251–1263

    Article  CAS  PubMed  Google Scholar 

  • Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M (2006) Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 60(12):1350–1355

    Article  CAS  PubMed  Google Scholar 

  • Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Muller CE, Salamone JD, Correa M (2012) Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-related decision making in mice. Neuropharmacology 62(5–6):2068–2077

    Article  CAS  PubMed  Google Scholar 

  • Pettibone DJ, Totaro JA, Pflueger AB (1984) Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants. Eur J Pharmacol 102:425–430

    Article  CAS  PubMed  Google Scholar 

  • Podurgeil SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, Lopez-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Muller CE, Correa M, Salamone JD (2013) The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience 250:507–519

    Article  Google Scholar 

  • Preskorn SH, Kent TA, Glotzbach RK, Irwin GH, Solnick JV (1984) Cerebromicrocirculatory defects in animal model of depression. Psychopharmacology 84:196–199

    Article  CAS  PubMed  Google Scholar 

  • Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 84(6):552–554

    Article  CAS  PubMed  Google Scholar 

  • Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow task: pharmacological studies and role of individual differences. PLoS One 7(10):e47934

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Muller CE, Correa M, Salamone JD (2014a) The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice tak: reversal with antidepressant drugs. PLoS One 9(6):e99320

  • Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M, Rowland M, Lopez-Cruz L, Correa M, Salamone JD (2014b) Bupropion increases selection of high effort activity in rats tested on progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol (in press)

  • Robbins TW, Everitt BJ (2007) A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology (Berl) 191:433–437

    Article  CAS  Google Scholar 

  • Rogers MA, Bradshaw JL, Phillips JG, Chiu E, Vaddadi K, Presnel I, Mileshkin C (2000) Parkinsonian motor characteristics in unipolar major depression. J Clin Exp Neuropsychol 22(2):232–244

    Article  CAS  PubMed  Google Scholar 

  • Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401:163–186

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Correa M (2002) Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137(1–2):3–25

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76(3):470–485

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991) Haloperidol and nucleus accumbens (DA) depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology 104:515–521

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens (DA) depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 65:221–229

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens (DA): empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341–359

    Article  CAS  PubMed  Google Scholar 

  • Salamone JD, Arizzi MN, Sandoval MD, Cervone KM, Aberman JE (2002) (DA) antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology (Berl) 160:371–380

    Article  CAS  Google Scholar 

  • Salamone JD, Correa M, Mingote SM, Weber SM, Farrar AM (2006) Nucleus accumbens (DA) and the forebrain circuitry involved in behavioral activation and effort-related decision making: implications for understanding anergia and psychomotor slowing in depression. Curr Psychiatr Rev 2:267–280

    Article  Google Scholar 

  • Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens (DA) and associated forebrain circuits. Psychopharmacology (Berl) 191:461–482

    Article  CAS  Google Scholar 

  • Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN (2009) Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of (DA) D2 antagonism. Behav Brain Res 201:216–222

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Salamone JD, Correa M, Farrar AM, Nunes EJ, Collins LE (2010) Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation. Future Neurol 5:377–392

    Article  CAS  Google Scholar 

  • Santerre JL, Nunes EJ, Randall PA, Baqi Y, Müller CE, Salamone JD (2012) Behavioral studies with the novel adenosine A2A antagonist MSX-4: reversal of the effects of (DA) D2 antagonism. Pharmacol Biochem Behav 102(4):477–487

    Article  CAS  PubMed  Google Scholar 

  • Schweimer J, Hauber W (2005) Involvement of the rat anterior cingulate cortex in control of instrumental response guided by reward expectancy. Learn Mem 12(3):334–342

    Article  PubMed Central  PubMed  Google Scholar 

  • Shafiei N, Gray M, Viau V, Floresco SB (2012) Acute stress induces selective alterations in cost/benefit decision-making. Neuropsychopharmacology 37(10):2194–2209

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Silverman K, Evans SM, Strain EC, Griffiths RR (1992) Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 327(16):1109–1114

    Article  CAS  PubMed  Google Scholar 

  • Sommer S, Danysz W, Russ H, Valastro B, Flik G, Hauber W (2014) The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. Int J Neuropsychopharmacol

  • Soskin DP, Holt DJ, Sacco GR, Fava M (2013) Incentive salience: novel treatment strategies for major depression. CNS Spectr 1:1–8

    Google Scholar 

  • Stahl SM (2002) The psychopharmacology of energy and fatigue. J Clin Psychiatry 63(1):7–8

    Article  PubMed  Google Scholar 

  • Svenningsson P, Le Moine C, Fisone G, Fredholm BB (1999) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355–396

    Article  CAS  PubMed  Google Scholar 

  • Tanra AJ, Kagaya A, Okamoto Y, Muraoka M, Motohashi N, Yamawaki S (1995) TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats. Prog Neuropsychopharmacol Biol Psychiatry 19(5):963–971

    Article  CAS  PubMed  Google Scholar 

  • Todder D, Caliskan S, Baune BT (2009) Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression. World J Biol Psychiatry 10(4):276–284

    Article  PubMed  Google Scholar 

  • Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35:537–555

    Article  PubMed Central  PubMed  Google Scholar 

  • Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012) Effort-based decision making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121(3):553–558

    Article  PubMed Central  PubMed  Google Scholar 

  • Trifilieff P, Feng B, Urizar E, Winiger V, Ward RD, Taylor KM, Martinez D, Moore H, Balsam PD, Simpson EH, Javitch JA (2013) Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry 18:1025–1033

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Tylee A, Gastpar M, Lepine JP, Mendlewicz J (1999) DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 14:139–151

    CAS  PubMed  Google Scholar 

  • Walton ME, Bannerman DM, Alterescu K, Rushworth MFS (2003) Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J Neurosci 23:6475–6479

    CAS  PubMed  Google Scholar 

  • Wang H, Chen X, Li Y, Tang TS, Bezprozvanny I (2010) Tetrabenazine is neuroprotective in Huntington’s disease mice. Mol Neurodegener 5:18

    Article  PubMed Central  PubMed  Google Scholar 

  • Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H (2011) Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci 31(46):16597–16602

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB (2006) Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson’s disease. Brain Res Bull 70:312–321

    Article  CAS  PubMed  Google Scholar 

  • Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, Muller CE, Salamone JD (2009) The adenosine A2A antagonist MSX-3 reverses the effort-related effects of (DA) blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology 203:489–499

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Yamada K, Kobayashi M, Mori A, Jenner P, Kanda T (2013) Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents. Pharmacol Biochem Behav 114–115:23–30

    Article  PubMed  Google Scholar 

  • Yamada K, Kobayashi M, Shiozaki S, Ohta T, Mori A, Jenner P, Kanda T (2014) Antidepressant activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats. Psychopharmacology

Download references

Acknowledgments

This work was supported by a grant to J.S. from the National Institute of Mental Health (MH094966) and to M.C. from Fundació Bancaixa/U. Jaume I. (P1.1B2010-43), and a SURF grant to C. Freeman. Many thanks to Dr. Eric Nunes for his assistance.

Disclosure/Conflict of interest

J.S. has received grants from Merck-Serrono, Pfizer, Roche, Shire, and Prexa.

Author information

Authors and Affiliations

  1. Division of Behavioral Neuroscience, Department of Psychology, University of Connecticut, Storrs, CT, 06269-1020, USA

    Samantha E. Yohn, Christian Thompson, Patrick A. Randall, Christie A. Lee, Mercè Correa & John D. Salamone

  2. Department of Chemistry, North Carolina State University, Raleigh, NC, USA

    Christie A. Lee

  3. Universität Bonn, Pharma-Zentrum Bonn, Pharmazeutisches Institut, Pharmazeutische Chemie, Bonn, Germany

    Christa E. Müller & Younis Baqi

  4. Department of Chemistry, Faculty of Science, Sultan Qaboos University, PO Box 36, 123, Muscat, Oman

    Younis Baqi

  5. Àrea de Psicobiologia, Campus de Riu Sec, Universitat Jaume I, 12071, Castelló, Spain

    Mercè Correa

Authors
  1. Samantha E. Yohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick A. Randall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christie A. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christa E. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Younis Baqi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mercè Correa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John D. Salamone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D. Salamone.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yohn, S.E., Thompson, C., Randall, P.A. et al. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232, 1313–1323 (2015). https://doi.org/10.1007/s00213-014-3766-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-014-3766-0

Keywords

Search

Navigation